HIV/AIDS: 10 Persistent Global Challenges in 2024

Despite transformative progress, HIV/AIDS remains a global health crisis. UNAIDS 2023 data: 39.9 million PLHIV, 1.3 million new infections, 630,000 AIDS-related deaths.

Ten Enduring Challenges

  1. Scale of epidemic: 39.9M living with HIV; only 30.7M on ART (77%). 9.2M untreated.
  2. New infections plateau: 1.3M/year — far from 2025 target (<370K). Key populations: AGYW (adolescent girls/young women) in sub-Saharan Africa, MSM, PWID, sex workers, trans people globally.
  3. Inequitable access: 28% of children (0–14) on ART vs. 77% adults. Western/central Africa lag.
  4. Stigma & discrimination: Drives avoidance of testing, delayed linkage, poor adherence. Legal barriers (criminalization) persist in 134 countries.
  5. Treatment gaps: Stockouts, clinic distance, user fees, weak supply chains. Second/third-line ART access limited.
  6. COVID-19 disruption: Service interruptions, diverted resources, increased vulnerability.
  7. Drug resistance: Pre-treatment NNRTI resistance >10% in many regions → dolutegravir-based regimens critical.
  8. Youth vulnerability: 4,000 new infections/week among AGYW (15–24) in SSA. Comprehensive sexuality education & youth-friendly services lacking.
  9. Funding shortfall: $20.8B available (2022) vs. $29.3B needed (2025). Donor fatigue, domestic resource gaps.
  10. Comorbidities & aging: CVD, renal, bone, neurocognitive, cancers in long-term survivors — health systems unprepared.

Path Forward

  • 95-95-95 targets (diagnosed, on ART, suppressed).
  • Differentiated service delivery (multi-month dispensing, community ART).
  • PrEP scale-up (oral, CAB-LA, vaginal ring).
  • Integration with UHC, SRHR, TB, hepatitis programs.
  • Community-led monitoring & advocacy.

Ending AIDS as a public health threat by 2030 is possible—but only with political will, equity-centered financing, and human rights at the center.

HIV & AIDS - Related Articles